Table 1.
Anthropometric and laboratory characteristics of study subjects.
| Variable | Mean ± SD (Median; Range) |
|---|---|
| Age (years) | 11.8 ± 3.4 (12; 5–16) |
| Male, n (%) | 13 (54) |
| Female n (/%) | 11 (46) |
| BMI (kg/m2) | 38.0 ± 10.6 (38; 23–62) |
| BMI percentile | 98.9 ± 1.8 (99.6; 92.1–100) |
| BMI z-score | 2.6 ± 0.5 (2.7; 1.4–3.5) |
| Fasting glucose (mg/dL) a | 92.3 ± 9.4 (93; 67–110) |
| Total cholesterol (mg/dL) b | 179.8 ± 30.7 (178; 128–227) |
| LDL cholesterol (mg/dL) c | 109.9 ± 24.3 (111; 69–157) |
| HDL cholesterol (mg/dL) c | 42.8 ± 9.8 (41; 25–68) |
| Triglycerides (mg/dL) b | 130.7 ± 79.4 (116; 47–430) |
| AHI | 13.0 ± 12.1 (11; 1–48) |
| Mild OSA, (AHI 1–4), n (%) | 4 (17) |
| Moderate OSA (AHI 5–10), n (%) | 8 (33) |
| Severe OSA (AHI > 10), n (%) | 12 (50) |
| Total Arousal Index | 17.3 ± 11.9 (12, 5–43) |
| Respiratory event related arousals (%) | 46.6 ± 25 (44.5, 11–95) |
| CPAP, n (%) | 17 (71) |
| Adenotonsillectomy, n (%) | 5 (21) |
| BPAP, n (%) | 1 (4) |
| Flonase, n (%) | 1 (4) |
| Total Recording Time (minutes) | 326 ± 137.2 (266; 155–539) |
| Total Sleep Time (minutes) | 283.1 ± 122.4 (241.5; 124.5–487) |
| Sleep Efficiency (%) | 87 ± 9 (89.6; 67.4–98.1) |
a n = 18; b n = 24; c n = 22; BMI = body mass index; LDL = low-density lipoprotein; HDL = high-density lipoprotein; AHI = apnea–hypopnea index; OSA = obstructive sleep apnea; CPAP = continuous positive airway pressure; BPAP = bilevel positive airway pressure device.